KRT7 and cancer: In addition, CrD-SBC patients with co-expression of MUC5AC and CK7 by the cancer (15 cases) featured a worse prognosis in comparison with those negative for both markers (17 cases) or with expression of either MUC5AC or CK7 (20 cases) (Fig. 3c).